Back to all people

Alexei Ionan

FDA

3 appearances in the program

Sessions & presentations

PS21: FDA's CDER and CBER PDUFA VII Guidance on Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Development and Implementation

Parallel · Thu, Sep 17 , 4:15 PM

Organizer

PS21: FDA's CDER and CBER PDUFA VII Guidance on Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Development and Implementation

Parallel · Thu, Sep 17 , 4:15 PM

Chair

PS27: Harmonizing the Estimand Framework and Product Labeling: An Industry and Regulatory Perspective

Presentation: Regulatory Perspective

Parallel · Fri, Sep 18 , 8:30 AM

Presenting Author

↑